Survival outcomes of secondary cancers in patients with waldenström macroglobulinemia: An analysis of the SEER database
Survival outcomes of secondary cancers in patients with waldenström macroglobulinemia: An analysis of the SEER database
J. Castillo,A. Olszewski,3 Authors,S. Treon
2015 · DOI: 10.1002/ajh.24052
American journal of hematology/oncology · 24 Citations
TLDR
The survival of WM patients with colorectal cancer, melanoma, and NHL is worse than among general population controls, arguing in favor of age‐appropriate cancer screening.